Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.210 -0.010 (-0.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Appoints New Directors
From Treace Medical Concepts, Inc.
Via GlobeNewswire
5 Analysts Have This to Say About Treace Medical Concepts
Within the last quarter, Treace Medical Concepts (NASDAQ:TMCI) has observed the following analyst ratings: 
Via Benzinga
Where Treace Medical Concepts Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Treace Medical Concepts (NASDAQ:TMCI) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Treace Medical Shares Interim Data From Corrective Toe Surgery Trial
Via Benzinga
Analyst Ratings for Treace Medical Concepts
Within the last quarter, Treace Medical Concepts (NASDAQ:TMCI) has observed the following analyst ratings: 
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Recap: Treace Medical Concepts Q2 Earnings
  Treace Medical Concepts (NASDAQ:TMCI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. 
Via Benzinga
Treace to Host Surgeon Advisor Event on September 20, 2022
From Treace Medical Concepts, Inc.
Via GlobeNewswire
4 Analysts Have This to Say About Treace Medical Concepts
Over the past 3 months, 4 analysts have published their opinion on Treace Medical Concepts (NASDAQ:TMCI) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Treace Medical Clocks 40% Jump In Q4 Sales On Higher Volume, FY22 Guidance Better Than Expected
Treace Medical Concepts Inc (NASDAQ: TMCI) Q4 FY21 sales increased 39% to $33.4 million, beating the consensus of $32.27 million, driven by an increased number of... 
Via Benzinga
Treace Medical Concepts, Inc. (TMCI) Q3 2021 Earnings Call Transcript
TMCI earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Treace Medical Concepts, Inc. (TMCI) Q2 2021 Earnings Call Transcript
TMCI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... 
Via Benzinga
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,... 
Via Benzinga
55 Biggest Movers From Friday
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World... 
Via Benzinga
Earnings Scheduled For May 25, 2021
Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is likely to report quarterly earnings at $1.40 per share on revenue of $1.10 billion. • Burning... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media... 
Via Benzinga
Topics Government
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021
Upgrades Seaport Global upgraded the previous rating for Public Service Enterprise Group Inc (NYSE:PEG) from Neutral to Buy. Public Service Enterprise earned $1.28 in the... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE... 
Via Benzinga
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... 
Via Benzinga
Treace Medical's Lapiplasty 3D Associated With Early Weightbearing After Foot Surgery, Interim Data Shows
Medical device company Treace Medical Concepts Inc (NASDAQ: TMCI) has announced interim results from the ALIGN3D clinical study, a post-market 5-year study... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,... 
Via Benzinga
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
38 Stocks Moving In Monday's Mid-Day Session
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.